Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELENA A CHRISTOFIDES

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1306893433
CMS profile
58640
Location
COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$353,383.33

507 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 11; records 101–150 of 507 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELENA A CHRISTOFIDES

NPI 1306893433 · CMS profile ID 58640

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 11; records 101–150 of 507 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1306893433?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELENA A CHRISTOFIDES, NPI 1306893433, CMS profile ID 58640. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 11; records 101–150 of 507 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1306893433?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ELENA A CHRISTOFIDES, NPI 1306893433, CMS profile ID 58640. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 11; records 101–150 of 507 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1306893433?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ELENA A CHRISTOFIDES, NPI 1306893433, CMS profile ID 58640, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 11; records 101–150 of 507 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1306893433?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

507 matching records · $353,383.33 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 507 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 507.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer HealthCare Pharmaceuticals Inc. $4,850.0009/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930119483 CMS
Bayer HealthCare Pharmaceuticals Inc. $107.6809/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930001569 CMS
Bayer HealthCare Pharmaceuticals Inc. $669.2609/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930119479 CMS
Lilly USA, LLC $1,100.0009/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918014141 CMS
Bayer HealthCare Pharmaceuticals Inc. $17.9009/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929986051 CMS
RECORDATI_RARE_DISEASES_INC. $5.6209/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 961609089 CMS
Xeris Pharmaceuticals, Inc. $14.1409/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946475491 CMS
Bayer HealthCare Pharmaceuticals Inc. $302.8509/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930247471 CMS
Lilly USA, LLC $1,050.0009/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918037623 CMS
Bayer HealthCare Pharmaceuticals Inc. $232.5909/02/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929975119 CMS
EUSA Pharma (US) LLC $14.1909/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 964301707 CMS
RECORDATI_RARE_DISEASES_INC. $14.1909/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 961609083 CMS
Bayer HealthCare Pharmaceuticals Inc. $116.5909/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930075299 CMS
SANOFI-AVENTIS U.S. LLC $42.1409/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938867023 CMS
Amryt Pharma Holdings Ltd $4,000.0008/31/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881045697 CMS
Amryt Pharma Holdings Ltd $9.3608/31/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881045703 CMS
Amryt Pharma Holdings Ltd $78.2208/31/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881045711 CMS
Amryt Pharma Holdings Ltd $92.4408/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881045713 CMS
Amryt Pharma Holdings Ltd $4,000.0008/31/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881045719 CMS
Corcept Therapeutics $42.5008/31/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948779691 CMS
Lilly USA, LLC $1,925.0008/31/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917985813 CMS
Lilly USA, LLC $2,200.0008/31/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918037629 CMS
Novo Nordisk Inc $13.7808/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898642002 CMS
Ascendis Pharma, Inc. $38.4208/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563121 CMS
Ascendis Pharma, Inc. $193.7608/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563137 CMS
Ascendis Pharma, Inc. $52.7608/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563157 CMS
Ascendis Pharma, Inc. $557.0008/30/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563165 CMS
Ascendis Pharma, Inc. $338.5008/30/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563175 CMS
Ascendis Pharma, Inc. $406.4208/30/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563183 CMS
Ascendis Pharma, Inc. $5,200.0008/30/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563191 CMS
Ascendis Pharma, Inc. $101.9108/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563199 CMS
Ascendis Pharma, Inc. $29.3108/30/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942563207 CMS
Lilly USA, LLC $1,925.0008/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918027865 CMS
Lilly USA, LLC $2,200.0008/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918037631 CMS
Lilly USA, LLC $2,200.0008/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918027861 CMS
Lilly USA, LLC $17.1508/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917988413 CMS
Lilly USA, LLC $402.3508/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918037615 CMS
Lilly USA, LLC $767.9608/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918037617 CMS
Lilly USA, LLC $73.9108/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918067653 CMS
Lilly USA, LLC $167.7208/24/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917988405 CMS
Bayer HealthCare Pharmaceuticals Inc. $28.3608/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930223991 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $10.6808/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887374475 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $4.2808/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887423943 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7.4608/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887424051 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.4208/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887424053 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $182.8508/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887424055 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $982.6208/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887424057 CMS
Amryt Pharma Holdings Ltd $3,250.0008/17/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881045751 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $132.3208/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887424049 CMS
Lilly USA, LLC $1,100.0008/17/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917988411 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $403,194.41 701
PY2020 $291,383.79 408
PY2021 $307,770.86 417
PY2022 $353,383.33 507
PY2023 $224,813.66 375
PY2024 $298,800.34 433
PY2025 $424,213.35 568

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $3,981.65 16
PY2025 Principal investigator $223,421.90 9
PY2024 Recipient $67,466.00 2
PY2024 Principal investigator $265,162.62 38
PY2023 Recipient $11,582.26 9
PY2023 Principal investigator $345,066.59 44
PY2022 Recipient $26,027.00 2
PY2022 Principal investigator $87,584.45 39
PY2021 Recipient $910.92 7
PY2021 Principal investigator $54,818.50 18
PY2020 Principal investigator $107,279.27 51
PY2019 Principal investigator $142,158.25 33

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ortho-Clinical Diagnostics, Inc. $3,550.00 12/29/2025 Non-covered Recipient Entity
ENDOCRINOLOGY ASSOCIATES INC
Thyretain TSI Turbo_Stability Study Sample Collectiions No dispute reported 06/30/2026 1249804368
Principal investigator 1 Ortho-Clinical Diagnostics, Inc. $5,630.00 11/25/2025 Non-covered Recipient Entity
ENDOCRINOLOGY ASSOCIATES INC
Thyretain TSI Turbo_Stability Study Sample Collectiions No dispute reported 06/30/2026 1249804333
Principal investigator 1 Chiesi USA, Inc. $550.00 11/06/2025 Non-covered Recipient Entity
ENDOCRINOLOGY RESEARCH ASSOCIATES INC
MEASuRE: Metreleptin Effectiveness And Safety Registry (MEASuRE) No dispute reported 06/30/2026 1234407581
Principal investigator 1 Amgen Inc. $51,957.66 07/23/2025 Non-covered Recipient Entity
ENDOCRINOLOGY ASSOCIATES INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246641249
Principal investigator 1 Chiesi USA, Inc. $699.00 07/03/2025 Non-covered Recipient Entity
ENDOCRINOLOGY RESEARCH ASSOCIATES INC
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy No dispute reported 06/30/2026 1234403949
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298975
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298977
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298979
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298981
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298983
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298985
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298987
Recipient RECORDATI_RARE_DISEASES_INC. $332.00 06/04/2025 Covered Recipient Physician LCI699-RECAG-PASS-0572 No dispute reported 06/30/2026 1192298989
Recipient Corcept Therapeutics $268.48 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161932
Recipient Corcept Therapeutics $59.00 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161936
Recipient Corcept Therapeutics $71.74 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161948
Recipient Corcept Therapeutics $76.44 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161951
Recipient Corcept Therapeutics $98.62 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161955
Recipient Corcept Therapeutics $32.67 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161959
Recipient Corcept Therapeutics $371.77 05/01/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161940
Recipient Corcept Therapeutics $346.93 05/01/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214161944
Principal investigator 1 Chiesi USA, Inc. $500.00 04/10/2025 Non-covered Recipient Entity
ENDOCRINOLOGY RESEARCH ASSOCIATES INC
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy No dispute reported 06/30/2026 1234399686
Principal investigator 1 Chiesi USA, Inc. $8,000.00 04/10/2025 Non-covered Recipient Entity
ENDOCRINOLOGY RESEARCH ASSOCIATES INC
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy No dispute reported 06/30/2026 1234399689
Principal investigator 1 Eli Lilly and Company $827.24 01/31/2025 Non-covered Recipient Entity
REMINGTON-DAVIS, INC.
A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH SEMAGLUTIDE ONCE WEEKLY IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN WITH OR WITHOUT SGLT2 INHIBITOR (TRANSCEND-T2D-2) No dispute reported 06/30/2026 1187887866
Principal investigator 1 Eli Lilly and Company $151,708.00 01/07/2025 Non-covered Recipient Entity
REMINGTON-DAVIS, INC.
A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RETATRUTIDE ONCE WEEKLY COMPARED WITH SEMAGLUTIDE ONCE WEEKLY IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN WITH OR WITHOUT SGLT2 INHIBITOR (TRANSCEND-T2D-2) No dispute reported 06/30/2026 1187887864